Search research articles
Contact Us
Filters
Showing results (61-70 of 138) with videos related to
Page
of 14
Sort By:
BMC Cancer
|
July 2, 2017
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole
Angela George, Jennifer McLachlan, Nina Tunariu, et al.
BJU International
|
February 12, 2005
Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma
Sarbjinder S Sandhu, Andrew Symes, Roger A'Hern, et al.
EJNMMI Research
|
June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PET
Laura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.
Melanoma Research
|
May 14, 2009
Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma
Tim Eisen, José Thomas, Wilson H Miller, et al.
Gynecologic Oncology
|
August 31, 2015
Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC)
Heike Seifert, Alexandros Georgiou, Helen Alexander, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2014
Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)
Antonio Gonzalez-Martin, Laurence Gladieff, Bengt Tholander, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2020
Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma
Henry G Smith, Jessica Glen, Nancy Turnbull, et al.
Future Oncology (London, England)
|
June 30, 2015
Bisphosphonates in patients with renal cell carcinoma and bone metastases: a sunitinib global expanded-access trial subanalysis
Eduard Vrdoljak, Martin Gore, Sophie Leyman, et al.
Cancer Gene Therapy
|
March 28, 2002
Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells
Francis J Burrows, Martin Gore, W Russell Smiley, et al.
ESMO Open
|
March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 138) with videos related to
Sort By:
Page
of 14
BMC Cancer
|
July 2, 2017
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole
Angela George, Jennifer McLachlan, Nina Tunariu, et al.
BJU International
|
February 12, 2005
Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma
Sarbjinder S Sandhu, Andrew Symes, Roger A'Hern, et al.
EJNMMI Research
|
June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PET
Laura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.
Melanoma Research
|
May 14, 2009
Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma
Tim Eisen, José Thomas, Wilson H Miller, et al.
Gynecologic Oncology
|
August 31, 2015
Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC)
Heike Seifert, Alexandros Georgiou, Helen Alexander, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2014
Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)
Antonio Gonzalez-Martin, Laurence Gladieff, Bengt Tholander, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2020
Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma
Henry G Smith, Jessica Glen, Nancy Turnbull, et al.
Future Oncology (London, England)
|
June 30, 2015
Bisphosphonates in patients with renal cell carcinoma and bone metastases: a sunitinib global expanded-access trial subanalysis
Eduard Vrdoljak, Martin Gore, Sophie Leyman, et al.
Cancer Gene Therapy
|
March 28, 2002
Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells
Francis J Burrows, Martin Gore, W Russell Smiley, et al.
ESMO Open
|
March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma
Kok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
Page
of 14